B-cell depletion fails to abrogate the induction of oral tolerance of specific Th1 immune responses in mice

Scandinavian Journal of Immunology

Volumn 51, Issue 5, 2000, Pages 454-460

  Peng, ^a   Chang, ^b   Lee, ^c   Kuo, ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HELPER CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTES; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE DEPLETION; MALE; MICE; OVALBUMIN; RABBITS; SPLEEN; TH1 CELLS;

EID: 0034057677     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00700.x     Document Type: Article

References (36)

1. 1 Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann NY Acad Sci 1996;778:1-27.
2. 2 Husby S, Mestecky J, Moldoveanu Z et al. Oral tolerance humans: T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663-70.
3. 3 Thompson HSG, Staines NA. Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today 1990;11:396-9.
4. 4 Trentham DE, Dynesius-Trentham RA, Orav EJ. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261:1727-30.
5. 5 Weiner HL, Mackin GA, Matsui M. Double-blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis. Science 1993;259:1321-4.
6. 6 Furrie E, Turner MW, Strobel S. Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system. Immunology 1994;83:562-7.
7. 7 Bruce MG, Strobel S, Hanson DG, Ferguson A. Irradiated mice lose the capacity to 'process' fed antigen for systemic tolerance of delayed-type hypersensitivity. Clin Exp Immunol 1987;70:611-18.
8. 8 Hanson DG, Vaz NM, Rawlings LA, Lynch JM. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization. J Immunol 1979;122:2261-6.
9. 9 Furrie E, Turner MW, Strobel S. Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppresses delayed-type hypersensitivity in recipient mice. Immunology 1995;86:480-6.
10. 10 Cassell DJ, Schwartz RH. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med 1994;180:1829-40.
11. 11 Ronchese F, Hausmann B. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med 1993;177:679-90.
12. 12 Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992;258:1156-9.
13. 13 Lassila O, Vainio O, Matzinger P. Can B cells turn on virgin T cells? Nature 1988;334:253-5.
14. 14 Ho WY, Cooke MP, Goodnow CC, Davis MM. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994;179:1539-49.
15. 15 Eynon EE, Parker DC. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992;175:131-8.
16. 16 Croft M, Joseph SB, Miner KT. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. J Immunol 1997;159:3257-65.
17. 17 Yuschenkoff VN, Sethna MP, Freeman GJ, Parker DC. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J Immunol 1996;157:1987-95.
18. 18 Buhlmann JE, Foy TM, Aruffo A et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995;2:645-53.
19. 19 Mowat AM, Thomas MJ, MacKenzie S, Parrott DM. Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology 1986;58:677-83.
20. 20 Flood PM, Janeway CA Jr, Gershon RK. B cell deprived mice lack functional expression of certain T suppressor cell subsets. J Mol Cell Immunol 1984;1:107.
21. 21 Sy MS, Lowy A, Hayglass R, et al. Chronic treatment with rabbit anti-mouse μ-chain antibody alters the characteristic immunoglobulin heavy chain restriction of murine suppressor T cell factors. Proc Natl Acad Sci USA 1984;81:3846-50.
22. 22 Hayglass KT, Naides SJ, Scott CF Jr, Benacerraf B, Sy M. T cell development in B cell-deficient mice IV. The role of B cells as antigen-presenting cells in vivo. J Immunol 1986;136:823-9.
23. 23 Janeway CA Jr, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol 1987;138:1051-5.
24. 24 Ron Y, Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol 1987;138:2848-56.
25. 25 Kurt-Jones EA, Liano D, Hayglass KA, Benacerraf B, Sy M, Abbas AK. The role of antigen-presenting B cells in T cell priming in vivo studies of B cell-deficient mice. J Immunol 1988;140:3373-8.
26. 26 Cerny A, Kimoto M, Hugin AW, Merino R, Izui S. Anti-IgM treatment of C57BL/6-1pr/1pr mice: depletion of B cells reduces 1pr gene-induced lymphoproliferation and mononuclear cell vasculitis. Clin Exp Immunol 1989;77:124-9.
27. 27 Peng HJ, Chang ZN, Hun SH et al. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scand J Immunol 1995;42:297-304.
28. 28 Metlay JP, Pure E, Steinman RM. Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J Exp Med 1989;169:239-54.
29. 29 Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 1994;152:5723-33.
30. 30 Peng HJ, Turner MW, Strobel S. The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol 1990;81:510-15.
31. 31 Galliaerde V, Desvignes C, Peyron E, Kaiserlian D. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro. Eur J Immunol 1995;25:1385-90.
32. 32 Porta C, James PS, Phillips AD, Savidge TC, Smith MW, Cremaschi D. Confocal analysis of fluorescent bead uptake by mouse Peyer's patch follicle-associated M cells. Exp Physiol 1992;77:929-32.
33. 33 Enders G, Gottwald T, Brendel W. Induction of oral tolerance in rats without Peyer's patches. Immunology 1986;58:311-14.
34. 34 Williams NA, Wilson AD, Bailey M, Bland PW, Stokes CR. Primary antigen-specific T-cell proliferative responses following presentation of soluble protein antigen by cells from the murine small intestine. Immunology 1992;75:608-13.
35. 35 Bland PW, Whiting CV. Differential control of major histocompatibility complex class II I-EK alpha protein expression in the epithelium and in subsets of lamina propria antigen-presenting cells of the gut. Immunology 1993;79:107-11.
36. C+ dendritic cell population in mouse Peyer's patches. Eur J Immunol 1996;26:1801-6.